phenyl acetate has been researched along with Secondary Hyperparathyroidism in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Vos, JY; Elseviers, M | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; Dos Reis, LM; Draibe, SA; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Martin, CJ; Reams, SM | 1 |
| Nolan, CR; Qunibi, WY | 1 |
| González, A; Martín, F; Martínez, F; Sarró, F; Verdú, J | 1 |
| Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
| Friedman, EA | 1 |
| Drüeke, TB; Landais, P | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Henderson, IS; Jones, MC; McElduff, N; Pflanz, S | 1 |
| Bacchella, L; Bellazzi, R; de Vincenzi, A; Gazo, A; Gini, A; Nai, M; Romanini, D; Santagostino, M | 1 |
| Bonforte, G; Dozio, B; Scanziani, R; Surian, M | 1 |
| Janssen, MJ; ter Wee, PM; van Boven, WP; van der Kuy, A | 2 |
| Albu, AT; Dungaciu, M; El Esper, N; Fournier, A; Mornière, P; Oprisiu, R | 1 |
| Llach, F; Yudd, M | 1 |
| Dohi, Y; Kanagawa, S; Yosikawa, Y | 1 |
5 review(s) available for phenyl acetate and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Treatment Outcome | 2003 |
Consequences and management of hyperphosphatemia in patients with renal insufficiency.
Topics: Acetates; Calcinosis; Calcium; Calcium Compounds; Cardiovascular Diseases; Diet; Humans; Hyperparathyroidism, Secondary; Phosphates; Renal Dialysis; Renal Insufficiency; Tomography, X-Ray Computed | 2005 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Current medical management of secondary hyperparathyroidism.
Topics: Acetates; Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Magnesium Compounds; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus, Dietary | 2000 |
5 trial(s) available for phenyl acetate and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?
Topics: Acetates; Adult; Biomarkers; Bone Diseases, Metabolic; Calcium Compounds; Chelating Agents; Chronic Disease; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Sevelamer; Time Factors; Treatment Outcome | 2010 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis.
Topics: Acetates; Acetic Acid; Adult; Aged; Calcium; Calcium Carbonate; Cross-Over Studies; Drug Tolerance; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Renal Dialysis | 1994 |
Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients.
Topics: Acetates; Analysis of Variance; Anemia; Calcium; Calcium Carbonate; Drug Administration Routes; Erythropoietin; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Uremia | 1995 |
Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Topics: Acetates; Acetic Acid; Aluminum Hydroxide; Calcium Carbonate; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Prospective Studies; Renal Dialysis; Time Factors | 1996 |
8 other study(ies) available for phenyl acetate and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
Topics: Acetates; Bone and Bones; Calcium Carbonate; Calcium Compounds; Dietetics; Epoxy Compounds; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphates; Phosphorus, Dietary; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2003 |
[MIBI and parathyroid gland function in secondary hyperparathyroidism].
Topics: Acetates; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Secretory Rate; Technetium Tc 99m Sestamibi; Uremia | 2004 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |
Calcium mass balance and behavior of intact immunoreactive parathyroid hormone in acetate-free biofiltration: acute and one-year evaluation.
Topics: Acetates; Adult; Aged; Aluminum Hydroxide; Bicarbonates; Calcitriol; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Hemodiafiltration; Hemodialysis Solutions; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism, Secondary; Magnesium Hydroxide; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Secretory Rate; Uremia | 1994 |
Effects of calcitriol pulse therapy per os in CAPD patients.
Topics: Acetates; Acetic Acid; Administration, Oral; Adult; Aged; Calcitriol; Calcium Carbonate; Humans; Hyperparathyroidism, Secondary; Magnesium; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory | 1994 |
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
Topics: Acetates; Calcifediol; Calcinosis; Calcium; Calcium Compounds; Capsules; Cardiovascular Diseases; Cross-Over Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2000 |
[Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure].
Topics: Acetates; Acetic Acid; Allantoin; Aluminum Hydroxide; Bicarbonates; Chronic Kidney Disease-Mineral and Bone Disorder; Citrates; Citric Acid; Drug Combinations; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium Hydroxide; Phosphates | 1991 |